[1]
|
Ponikowski, P., Voors, A.A., Anker, S.D., et al. (2016) 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). Developed with the Special Contribution of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure, 18, 891-975. https://doi.org/10.1002/ejhf.592
|
[2]
|
Jessup, M., Abraham, W.T., Casey, D.E., et al. (2009) 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration with the International Society for Heart and Lung Transplantation. Circulation, 119, 1977-2016. https://doi.org/10.1161/CIRCULATIONAHA.109.192064
|
[3]
|
Zhou, B. and Tian, R. (2018) Mitochondrial Dysfunction in Pathophysiology of Heart Failure. Journal of Clinical Investigation, 128, 3716-3726. https://doi.org/10.1172/JCI120849
|
[4]
|
Snipelisky, D., Chaudhry, S.P. and Stewart, G.C. (2019) The Many Faces of Heart Failure. Cardiac Electrophysiology Clinics, 11, 11-20. https://doi.org/10.1016/j.ccep.2018.11.001
|
[5]
|
Phan, T.T., Abozguia, K., Shivu, G.N., et al.(2009) Heart Failure with Preserved Ejection Fraction Is Characterized by Dynamic Impairment of Active Relaxation and Contraction of the Left Ventricle on Exercise and Associated with Myocardial Energy Deficiency. Journal of the American College of Cardiology, 54, 402-409. https://doi.org/10.1016/j.jacc.2009.05.012
|
[6]
|
Nunnari, J. and Suomalainen, A. (2012) Mitochondria: In Sickness and in Health. Cell, 148, 1145-1159. https://doi.org/10.1016/j.cell.2012.02.035
|
[7]
|
Frey, T.G. and Mannella, C.A. (2000) The Internal Structure of Mitochondria. Trends in Biochemical Sciences, 25, 319-324. https://doi.org/10.1016/S0968-0004(00)01609-1
|
[8]
|
Bensinger, R. (1967) Mitochondrial ATP Synthesis. The New England Journal of Medicine, 277, 315. https://doi.org/10.1056/NEJM196708102770619
|
[9]
|
Kolwicz, S.C., Purohit, S. and Tian, R. (2013) Cardiac Metabolism and Its Interactions with Contraction, Growth, and Survival of Cardiomyocytes. Circulation Research, 113, 603-616. https://doi.org/10.1161/CIRCRESAHA.113.302095
|
[10]
|
Reis, F.H.Z. (2024) Mitochondria and the Heart. European Heart Journal, 1, ehae031. https://doi.org/10.1007/978-3-030-85536-9_7
|
[11]
|
Kartha, C.C. (2011) Energy Metabolism in Cardiomyocyte. In: Kartha C.C., Eds., Cardiomyocytes in Health and Disease, Springer Nature, Beijing, 73-92.
|
[12]
|
Gallo, G., Rubattu, S. and Volpe, M. (2024) Mitochondrial Dysfunction in Heart Failure: From Pathophysiological Mechanisms to Therapeutic Opportunities. International Journal of Molecular Sciences, 25, 2667. https://doi.org/10.3390/Ijms25052667
|
[13]
|
Doenst, T., Nguyen, T.D. and Abel, E.D. (2013) Cardiac Metabolism in Heart Failure. Circulation Research, 113, 709-724. https://doi.org/10.1161/CIRCRESAHA.113.300376
|
[14]
|
Nguyen, B.Y., Ruiz‐Velasco, A., Bui, T., et al. (2019) Mitochondrial Function in the Heart: The Insight into Mechanisms and Therapeutic Potentials. British Journal of Pharmacology, 176, 4302-4318. https://doi.org/10.1111/bph.14431
|
[15]
|
Lopaschuk, G.D., Karwi, Q.G., Tian, R., et al. (2021) Cardiac Energy Metabolism in Heart Failure. Circulation Research, 128, 1487-1513. https://doi.org/10.1161/CIRCRESAHA.121.318241
|
[16]
|
Stanley, W.C., Recchia, F.A. and Lopaschuk, G.D. (2005) Myocardial Substrate Metabolism in the Normal and Failing Heart. Physiological Reviews, 85, 1093-1129. https://doi.org/10.1152/physrev.00006.2004
|
[17]
|
Peoples, J.N., Saraf, A., Ghazal, N., et al. (2019) Mitochondrial Dysfunction and Oxidative Stress in Heart Disease. Experimental & Molecular Medicine, 51, 1-13. https://doi.org/10.1038/s12276-019-0355-7
|
[18]
|
Sanz, R.L., Inserra, F., Menéndez, S.G., et al. (2023) Metabolic Syndrome and Cardiac Remodeling Due to Mitochondrial Oxidative Stress Involving Gliflozins and Sirtuins. Current Hypertension Reports, 25, 91-106. https://doi.org/10.1007/s11906-023-01240-w
|
[19]
|
Lazaropoulos, M.P. and Elrod, J.W. (2022) Mitochondria in Pathological Cardiac Remodeling. Current Opinion in Physiology, 25, Article ID: 100489. https://doi.org/10.1016/j.cophys.2022.100489
|
[20]
|
Ritterhoff, J. and Tian, R. (2023) Metabolic Mechanisms in Physiological and Pathological Cardiac Hypertrophy: New Paradigms and Challenges. Nature Reviews Cardiology, 20, 812-829. https://doi.org/10.1038/s41569-023-00887-x
|
[21]
|
Tsutsui, H., Kinugawa, S. and Matsushima, S. (2011) Oxidative Stress and Heart Failure. American Journal of Physiology-Heart and Circulatory Physiology, 301, H2181-2190. https://doi.org/10.1152/ajpheart.00554.2011
|
[22]
|
Bhatti, J.S., Bhatti, G.K. and Reddy, P.H. (2017) Mitochondrial Dysfunction and Oxidative Stress in Metabolic Disorders—A Step towards Mitochondria Based Therapeutic Strategies. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1863, 1066-1077. https://doi.org/10.1016/j.bbadis.2016.11.010
|
[23]
|
Tilokani, L., Nagashima, S., Paupe, V., et al. (2018) Mitochondrial Dynamics: Overview of Molecular Mechanisms. Essays in Biochemistry, 62, 341-360. https://doi.org/10.1042/EBC20170104
|
[24]
|
Ren, L., Chen, X., Chen, X., et al. (2020) Mitochondrial Dynamics: Fission and Fusion in Fate Determination of Mesenchymal Stem Cells. Frontiers in Cell and Developmental Biology, 8, Article ID: 580070. https://doi.org/10.3389/fcell.2020.580070
|
[25]
|
Menezes, T.N., Ramalho, L.S., Bechara, L.R.G., et al. (2020) Targeting Mitochondrial Fission-Fusion Imbalance in Heart Failure. Current Tissue Microenvironment Reports, 1, 239-247. https://doi.org/10.1007/s43152-020-00023-8
|
[26]
|
Liu, X., Guo, C. and Zhang, Q. (2023) Novel Insights into the Involvement of Mitochondrial Fission/Fusion in Heart Failure: From Molecular Mechanisms to Targeted Therapies. Cell Stress and Chaperones, 28, 133-144. https://doi.org/10.1007/s12192-023-01321-4
|
[27]
|
Liu, Y., Wang, Y., Bi, Y., et al. (2023) Emerging Role of Mitophagy in Heart Failure: From Molecular Mechanism to Targeted Therapy. Cell Cycle, 22, 906-918. https://doi.org/10.1080/15384101.2023.2167949
|
[28]
|
Yang, Y., Li, T., Li, Z., et al. (2020) Role of Mitophagy in Cardiovascular Disease. Aging and Disease, 11, 419-437. https://doi.org/10.14336/AD.2019.0518
|
[29]
|
Liu, M., Lv, J., Pan, Z., et al. (2022) Mitochondrial Dysfunction in Heart Failure and Its Therapeutic Implications. Frontiers in Cardiovascular Medicine, 9, Article ID: 945142. https://doi.org/10.3389/fcvm.2022.945142
|
[30]
|
Jiang, Q., Yin, J., Chen, J., et al. (2020) Mitochondria-Targeted Antioxidants: A Step towards Disease Treatment. Oxidative Medicine and Cellular Longevity, 2020, Article ID: 8837893. https://doi.org/10.1155/2020/8837893
|
[31]
|
Marín-García, J., Akhmedov, A.T. and Moe, G.W. (2013) Mitochondria in Heart Failure: The Emerging Role of Mitochondrial Dynamics. Heart Failure Reviews, 18, 439-456. https://doi.org/10.1007/s10741-012-9330-2
|
[32]
|
Wu, D., Dasgupta, A., Chen, K.H., et al. (2020) Identification of Novel Dynamin-Related Protein 1 (Drp1) GTPase Inhibitors: Therapeutic Potential of Drpitor1 and Drpitor1a in Cancer and Cardiac Ischemia-Reperfusion Injury. The FASEB Journal, 34, 147-1464. https://doi.org/10.1096/fj.201901467R
|
[33]
|
Ishikita, A., Matoba, T., Ikeda, G., et al. (2016) Nanoparticle-Mediated Delivery of Mitochondrial Division Inhibitor 1 to the Myocardium Protects the Heart from Ischemia-Reperfusion Injury through Inhibition of Mitochondria Outer Membrane Permeabilization: A New Therapeutic Modality for Acute Myocardial Infarction. Journal of the American Heart Association, 5, e003872. https://doi.org/10.1161/JAHA.116.003872
|
[34]
|
Disatnik, M.H., Ferreira, J.C.B., Campos, J.C., et al. (2013) Acute Inhibition of Excessive Mitochondrial Fission after Myocardial Infarction Prevents Long-Term Cardiac Dysfunction. Journal of the American Heart Association, 2, e000461. https://doi.org/10.1161/JAHA.113.000461
|
[35]
|
Shu, H., Peng, Y., Hang, W., et al. (2021) Trimetazidine in Heart Failure. Frontiers in Pharmacology, 11, Article ID: 569132. https://doi.org/10.3389/fphar.2020.569132
|
[36]
|
Lewis, J.F., Dacosta, M., Wargowich, T., et al. (1998) Effects of Dichloroacetate in Patients with Congestive Heart Failure. Clinical Cardiology, 21, 888-892. https://doi.org/10.1002/clc.4960211206
|
[37]
|
Rabanal-Ruiz, Y., Llanos-González, E. and Alcain, F.J. (2021) The Use of Coenzyme Q10 in Cardiovascular Diseases. Antioxidants, 10, Article No. 755. https://doi.org/10.3390/antiox10050755
|
[38]
|
Hoang, D.M., Pham, P.T., Bach, T.Q., et al. (2022) Stem Cell-Based Therapy for Human Diseases. Signal Transduction and Targeted Therapy, 7, 272. https://doi.org/10.1038/s41392-022-01134-4
|
[39]
|
Kieserman, J.M., Myers, V.D., Dubey, P., et al. (2019) Current Landscape of Heart Failure Gene Therapy. Journal of the American Heart Association, 8, e012239. https://doi.org/10.1161/JAHA.119.012239
|